Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

Eric Vallabh Minikel, Hien T. Zhao, Jason Le, Jill O'Moore, Rose Pitstick, Samantha Graffam, George A. Carlson, Michael P. Kavanaugh, Jasna Kriz, Jae Beom Kim, Jiyan Ma, Holger Wille, Judd Aiken, Deborah McKenzie, Katsumi Doh-Ura, Matthew Beck, Rhonda O'Keefe, Jacquelyn Stathopoulos, Tyler Caron, Stuart L. SchreiberJeffrey B. Carroll, Holly B. Kordasiewicz, Deborah E. Cabin, Sonia M. Vallabh

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology